These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 22644560

  • 1. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
    Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.
    Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.
    Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
    [Abstract] [Full Text] [Related]

  • 6. Utility of low dose (18)F-FDG PET-CT in patients with suspected colorectal carcinoma recurrence in conventional diagnostic methods.
    Ochoa-Figueroa MA, Uña-Gorospe J, Allende-Riera A, Cárdenas-Negro JC, Muñoz-Iglesias J, Cabello-García D, De Sequera-Rahola M, Martínez-Gimeno E.
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):249-56. PubMed ID: 23067526
    [Abstract] [Full Text] [Related]

  • 7. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.
    Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
    [Abstract] [Full Text] [Related]

  • 8. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY, Liang JA, Chen YK, Tsai CY, Kao CH.
    Hepatogastroenterology; 2006 Jun; 53(69):348-50. PubMed ID: 16795969
    [Abstract] [Full Text] [Related]

  • 9. Utility of 18-fluorodeoxyglucose positron emission/computed tomography in the management of recurrent colorectal cancer.
    Liong SY, Kochhar R, Renehan AG, Manoharan P.
    ANZ J Surg; 2012 Oct; 82(10):729-36. PubMed ID: 22989147
    [Abstract] [Full Text] [Related]

  • 10. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
    Khan K, Athauda A, Aitken K, Cunningham D, Watkins D, Starling N, Cook GJ, Kalaitzaki E, Chau I, Rao S.
    Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U, You J, McSweeney S, Freeman M, Hendler A.
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [Abstract] [Full Text] [Related]

  • 14. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU, Shiau YC, Tsai SC, Chao TH, Ho YJ, Kao CH.
    Anticancer Res; 2001 Mar; 21(2B):1375-8. PubMed ID: 11396217
    [Abstract] [Full Text] [Related]

  • 15. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
    Caglar M, Yener C, Karabulut E.
    Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
    [Abstract] [Full Text] [Related]

  • 16. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S, Stojiljkovic M, Sobic-Saranovic D, Pandurevic S, Brajkovic L, Milosevic I, Grozdic-Milojevic I, Artiko V.
    Neoplasma; 2017 Jul; 64(6):954-961. PubMed ID: 28895416
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 18. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.
    Lu YY, Chen JH, Chien CR, Chen WT, Tsai SC, Lin WY, Kao CH.
    Int J Colorectal Dis; 2013 Aug; 28(8):1039-47. PubMed ID: 23407908
    [Abstract] [Full Text] [Related]

  • 19. Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.
    Sarikaya I, Povoski SP, Al-Saif OH, Kocak E, Bloomston M, Marsh S, Cao Z, Murrey DA, Zhang J, Hall NC, Knopp MV, Martin EW.
    World J Surg Oncol; 2007 Jul 16; 5():80. PubMed ID: 17634125
    [Abstract] [Full Text] [Related]

  • 20. [¹⁸F-FDG PET/CT. Its correlation with carcinoembryonic antigen in patients with colorectal carcinoma].
    Granados Rangel O, Estrada G, Altamirano J.
    Gac Med Mex; 2014 Jul 16; 150(6):509-17. PubMed ID: 25375281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.